Wellington Management Group LLP Taro Pharmaceutical Industries LTD Transaction History

Wellington Management Group LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$70.26 - $76.64 $322,985 - $352,314	-4,597 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$70.48 - $79.95 $167,953 - $190,520	-2,383 Reduced 34.14%	4,597 $340,000
Q4 2020 Feb 12, 2021	SELL	$54.4 - $73.42 $402,016 - $542,573	-7,390 Reduced 51.43%	6,980 $513,000
Q3 2020 Nov 16, 2020	SELL	$54.41 - $68.2 $468,034 - $586,656	-8,602 Reduced 37.45%	14,370 $788,000
Q2 2020 Aug 14, 2020	SELL	$61.66 - $70.16 $565,175 - $643,086	-9,166 Reduced 28.52%	22,972 $1.53 Million
Q1 2020 May 14, 2020	SELL	$59.35 - $88.73 $298,115 - $445,690	-5,023 Reduced 13.52%	32,138 $1.97 Million
Q4 2019 Feb 11, 2020	BUY	$74.18 - $97.92 $2.76 Million - $3.64 Million	37,161 New	37,161 $3.27 Million

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.